Reactive metabolites are believed to be responsible for many types of toxicity, including idiosyncratic drug reactions. Bone marrow is a frequent target of idiosyncratic reactions, and, since these reactions have characteristics that suggest involvement of the immune system, the formation of reactive metabolites by leucocytes could also play a role in the aetiology of idiosyncratic drug reactions.
I 64 M yeloperoxidase toxicity, can also involve reactive metabolites. It appears that this can either involve direct cytotoxicity, such as in the case of acetaminophen, or an immunemedicated reaction such as halothane-induced hepatic necrosis. Despite the general acceptance of the involvement of reactive metabolites in adverse drug reactions, in most cases their involvement has not been demonstrated.
There are several types of reactive metabolites. Some metabolites are reactive because they are electron-deficient, i.e. electrophiles, while others are reactive because they possess an unpaired electron, i.e. free radicals. In general electrophiles react with nucleophiles. In biological systems the major nucleophiles are nitrogenbased, such as the &-amino group of lysine, or sulphur-based, such as the thiol group of cysteine. In contrast, free radicals usually abstract a hydrogen atom from other molecules rather than undergo covalent binding; however, free radicals can add to double bonds and, in addition to being free radicals, they can also be electrophilic, e.g. cation radicals. Abstraction of a hydrogen atom from a lipid can initiate a chain reaction leading to lipid peroxidation. There is a considerable amount of controversy as to whether specific adverse reactions are due to covalent modification of macromolecules by electrophiles or due to lipid peroxidation, oxidative 'stress' or other types of modification of biological molecules by free radicals [3,4].
The myeloperoxidase (MPO) system
Most drug and xenobiotic metabolism occurs in the liver, and although the liver is often involved in adverse drug reactions the incidence of adverse reactions involving other organs can be comparable. The incidence of adverse reactions involving the skin is higher than that of the liver and involvement of bone marrow and kidney is almost as high [5]. Although some reactive species, such as acyl glucuronides [6], can easily reach the circulation, most are probably too reactive to escape from the organ in which they were formed. Therefore it is likely that if reactive metabolites are involved in bone-marrow toxicity, they would be formed in the bone marrow [7, 8] . Although leucocytes appear to contain cytochromes P-450 [9], the amount is very small and we have been unable to detect metabolism in leucocytes catalysed by cytochromes P-450 [lo]. The major oxidant system of leucocytes, specifically neutrophils and monocytes, is a combination of N A D P H oxidase and M P O [11,12]. N A D P H oxidase converts oxygen into superoxide which is in turn converted into hydrogen peroxide. Hydrogen peroxide oxidizes MPO to a form of the enzyme referred to as compound I, which is a general term for the two-electron oxidation product of a peroxidase. Although compound I can probably oxidize drugs and xenobiotics directly, the major substrate is the chloride ion. Chloride ion is oxidized to hypochlorite, which is known to be a powerful oxidant and can oxidize other compounds. However, recent kinetic evidence suggests that the free hypochlorite is not the oxidizing species, at least in the oxidation of taurine, but instead the chlorine atom remains attached to the enzyme until it is transferred to the product [13]. The distinction may not be very important since the products formed by the combination of MPO/H,O,/Clappear to be the same as those formed by hypochlorite [14]. In addition to this oxidation pathway, there is recent evidence for the reaction of superoxide with M P O to form an oxidant which results in products similar to those expected for reaction with hydroxy radical [15] . The N A D P H oxidase/MPO system can generate a large amount of oxidant. Presumably the major function of this oxidant system is to kill bacteria and other pathogens; however, there is evidence that it is also involved in the regulation of proteolytic enzymes and may have other functions as well [12, 16] . An important characteristic of this system is that it requires activation of the cells by a stimulus like bacteria in order to activate the N A D P H oxidase and for release of the MPO from granules. If reactive metabolites formed by this system are responsible for idiosyncratic drug reactions, it would follow that an infection or other inflammatory condition would be one risk factor of the development of the adverse reaction.
Other oxidizing systems exist in leucocytes. Nitric oxide is produced by murine neutrophils but it appears that human neutrophils produce little or no nitric oxide [17-191. Leucocytes also contain prostaglandin synthase; however, this is quantitatively less important than the MPO system and we have been unable to detect evidence of drug oxidation by this pathway [2O] .
Oxidation of specific drugs by the MPO system
Most of the products formed by the MPO system are the same as would be expected for a drug with hypochlorite [14]. The reaction presumably involves the reaction of an electrophilic chlorine with an electron-rich atom such as nitrogen or sulphur. Unlike oxidation by cytochromes P-450, oxidation of carbon by MPO is uncommon but it can occur. One example is the hydroxylation and chlorination of phenylbutazone [21] . Similar products are also observed on incubation of a drug with activated neutrophils or monocytes as with hypochlorite.
Oxidation of primary arylamines leads to hydroxylamines and chloramines (Fig. 1) . The hydroxylamine is further oxidized to a nitroso derivative and in some cases a nitro derivative. The nitroso derivative appears to be responsible for much of the covalent binding. The chloramine appears to be more active as a chlorinating agent rather than leading to covalent binding of the drug to biological molecules. We have not observed free-radical intermediates in these reactions but we have not looked for them carefully. Examples of drugs which are primary amines and are oxidized in this manner include dapsone [2O], sulphonamides [22] and procainamide [23] .
Although not a primary arylamine, clozapine contains a nitrogen which is easily oxidized, presumably to an N-chloro derivative that rapidly looses a chloride ion to form a nitrenium ion [24] . The putative nitrenium ion of clozapine is red in colour and reacts rapidly with glutathione to form several conjugates, at least some of which have the glutathione bound to one or both of the aromatic rings. (Fig. 2) . From the structures of the products, it appears that it is the quinone analogue rather than the cation radical that is responsible for reaction with nucleophiles such as glutathione. By use of radiolabelled drug it appears that almost 5% of vesnarinone incubated with activated neutrophils becomes covalently bound to the neutrophils.
Another type of compound containing more than one nitrogen is aminopyrine. It has been known for some time to be oxidized to a cation radical by peroxidases including MPO. More recently we produced spectral and kinetic evidence that oxidation of aminopyrine to a cation radical by hypochlorite involves a reactive dication intermediate with a half-life of about 15 ms [29] (Fig. 3) . As with vesnarinone, either the electrophilic dication or the cation radical could be responsible for the toxicity of aminopyrine, specifically agranulocytosis.
Drugs that contain nitrogen in the form of a hydrazine are also readily oxidized to reactive intermediates by hypochlorite, MPO/H,O,/Cl-, or activated neutrophils [30-321. In this case reactive diazines and diazonium ions appear to be involved, but free radicals are also possible.
Drugs that contain a sulphur such as a sulphydryl group are also easily oxidized. Propylthiouracil is oxidized all the way to a sulphonic acid [33,34]. The sulphonic acid is reactive and reacts with glutathione. In addition, we presume that formation of a reactive sulphenyl chloride is the first step in the reaction but we have not been able to prove this. The only evidence for the sulphenyl chloride is that the first product observed is a disulphide, which is presumably due to the reaction of the sulphenyl chloride with another molecule of the drug. 
Association of MPO-mediated reactive metabolite formation with adverse drug reactions
It is relatively easy to demonstrate that specific drugs are oxidized by the MPO/H202/C1-system to reactive intermediates, but it is much more difficult to demonstrate the significance of these products in adverse drug reactions. In general, use of the drugs described above is associated with a relatively high incidence of idiosyncratic drug reactions, especially agranulocytosis, drug-induced lupus and generalized reactions involving the skin and other organs [7,8]. For example, clozapine, aminopyrine, vesnarinone, propylthiouracil, dapsone and procainamide are all associated with a high incidence of agranulocytosis. It is reasonable to speculate that reactive metabolites produced by the M P O system are responsible for many of these reactions, especially reactions, such as agranulocytosis, that involve the bone marrow; however, proof of this hypothesis is difficult to obtain. There appears to be a higher incidence of agranulocytosis in patients taking vesnarinone who also received influenza vaccine. This also fits the hypothesis because influenza vaccine is capable of activating neutrophils which would lead to the formation of reactive metabolite. In several cases both electrophiles and free radicals are produced and there is no evidence to indicate which may be responsible for the observed toxicity.
The pathological mechanism for most of these adverse reactions is also unknown. The unpredictable nature of idiosyncratic reactions suggests involvement of the immune system, yet with few exceptions this has not been proven. Of the idiosyncratic reactions caused by the drugs described above, certainly druginduced lupus must involve the immune system because lupus is an autoimmune disease. There is good evidence that aminopyrine-induced agranulocytosis is due to an antibody against mature neutrophils [35,36]. Covalent binding of a reactive metabolite to a biological macromolecule could convert the metabolite into a hapten which could induce either an antibody or cell-mediated response. However, the mechanism of drug-induced agranulocytosis associated with the other drugs discussed is less clear. Although antibodies have been described in association with other drug-induced agranulocytosis, especially amodiaquine [37], propylthiouracil [38] and procainamide [39], the target appears to be the bone marrow rather than mature neutrophils. In addition, the time course of recurrence on re-exposure to the drug, an average of 14 weeks for clozapine [40], would be extremely unusual for an amnestic response of the immune system. There is evidence that direct toxicity may be involved in some cases [41], but then it is difficult to explain the idiosyncratic nature of the toxicity and the lack of toxicity to animals at high dose. Much work remains to be done before it will be possible to say with a reasonable degree of certainty that MPO-mediated reactive-metabolite formation is responsible for a significant number of adverse drug reactions.
Mechanisms by which MPO-generated reactive intermediates may mediate therapeutic effects of drugs
The generation of reactive oxygen species by activated neutrophils and monocytes is believed to be responsible for, or contribute to, many serious illnesses. Many of the same drugs that are metabolized by the M P O system and cause toxicity also have anti-inflammatory effects [42]. This could be due to inhibition of neutrophil and macrophage function by the reactive metabolites produced. Examples include the use of dapsone for the treatment of dermatitis herpetiformis (a vesicular disease associated with an infiltration of neutrophils in the skin) and rheumatoid arthritis; the use of propylthiouracil for the treatment of thyroid disease (in this case because of the inhibition of thyroid peroxidase which is similar to MPO) and alcoholic liver disease [43]; the use of aminopyrine for the treatment of pain, fever and inflammation and the use of 5-aminosalicylic acid for the treatment of inflammatory bowel disease. There is even evidence that patients who are on chronic dapsone therapy for leprosy have a lower incidence of Alzheimer's disease [44]. It has been hypothesized that this is due to inhibition of microglial cells which are the macrophages of the brain and may be responsible for the death of neurons in Alzheimer's disease.
Summary
The MPO system of neutrophils and monocytes can oxidize a large number of drugs to chemically reactive metabolites. Circumstantial evidence suggests that these reactive metabolites may be responsible for idiosyncratic drug reactions, especially those involving leucocytes, such as agranulocytosis and lupus. The same reactive metabolites may also be responsible for some of the therapeutic effects of drugs if they inhibit leucocyte function during an inflammatory reaction. 
